Newborn Screening for Early Childhood Cancer Predisposition Syndromes |
Baylor College of Medicine / Sharon Plon, M.D./ Ph.D. |
Crazy 8 Awards |
2025 |
Texas |
Towards LNP Vaccine Immune-Interception for Childhood Cancer Predisposition Syndromes |
Hospital for Sick Children / Uri Tabori, MD |
Crazy 8 Awards |
2025 |
Ontario |
Metabolic engineering of CD70CAR T cells to enhance immunotherapy targeting DIPG |
Mayo Clinic Jacksonville / Loic Deleyrolle, PhD |
Reach Grants |
2024 |
Florida |
Investigating mechanistic roles of a novel oncofusion-driven transcript isoform in Ewing sarcoma |
BC Cancer (Provincial Health Services Authority) / Poul Sorensen, MD/PhD |
Innovation Grants |
2024 |
British Columbia |
Targeting cancer-specific non-protein molecular signatures for immunotherapy of pediatric AML
|
Hackensack Meridian Health Center for Discovery and Innovation / Johannes Zakrzewski, MD |
Innovation Grants |
2024 |
New Jersey |
Widening the therapeutic index for pediatric medulloblastoma by targeting BET proteins |
Harvard University / Kristopher Sarosiek, Ph.D. |
R Accelerated Award Grants |
2024 |
Massachusetts |
Dissecting the role and mechanism of MLLT10 fusion proteins to treat pediatric leukemia |
The Trustees of the University of Pennsylvania / Kathy Fange Liu, Ph.D. |
R Accelerated Award Grants |
2024 |
Pennsylvania |
Uridine is a Targetable Metabolic Dependency in Acute Lymphoblastic Leukemia |
Board of Trustees of the Leland Stanford Junior University / Kara Davis, D.O. |
R Accelerated Award Grants |
2024 |
California |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic |
Baylor College of Medicine / Robin Parihar, MD/PhD |
Reach Grants |
2024 |
Texas |
Exploring the Interplay of Microbiome, Bile Acids, Immune Reconstitution, and Clinical Outcomes Following Allogeneic Hematopoietic Transplantation in Pediatrics |
Memorial Sloan-Kettering Cancer Center / Oriana Miltiadous, MD |
Reach Grants |
2024 |
New York |